Implantable Cardiac Monitor (ICM)

Implantable cardiac monitors (ICM) are small electrophysiology (EP) devices that used for long-term monitoring of a patient's heart electrical activity to detect arrhythmias. The technology can eliminate the need for a bulkly external Holter monitor that requires wire leads attached to the patient. ICMs can be inserted under the skin during and office visit and record cardiac data continuously for up to 4.5 years. 

News | Atrial Fibrillation

September 8, 2021 — Continuous heart rhythm monitoring – with anticoagulation if atrial fibrillation is detected – does ...

Home September 08, 2021
Home
News | Implantable Cardiac Monitor (ICM)

August 9, 2021 - In association with Heart Rhythm 2021, Biotronik today announced that the latest implantable cardiac ...

Home August 09, 2021
Home
In the past decade there has been a proliferation of clinical-grade wearable monitors and implantable devices such as pacemakers, ICDs, implantable cardiac monitors, and new pacemaker-like devices that can control hypertension. In the near future, these devices will be tied into a body-wide internet of things for specific patients that can transmit patient data to clinicians wirelessly to enable an integrated, more robust form of telecardiology and telemedicine.
Feature | Telecardiology | Victor Wollesen

Cardiovascular diseases are among the leading causes of death for people over 65 years old in North America and Europe ...

Home July 23, 2021
Home
News | Implantable Cardiac Monitor (ICM)

June 13, 2021 — Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the ...

Home July 14, 2021
Home
News | Cardiac Diagnostics

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
News | EP Lab

June 2, 2021 — Implicity, a leader in remote patient monitoring software and cardiac data management solutions ...

Home June 02, 2021
Home
News | EP Lab

May 14, 2021 — The U.S. Food and Drug Administration (FDA) is advising patients and caregivers to keep any consumer ...

Home May 14, 2021
Home
News | EP Lab

April 26, 2021 — Patients receiving an implantable cardioverter defibrillator (ICD) should be regularly screened for ...

Home April 26, 2021
Home
Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.
Feature | EP Lab | By Maninder Bedi, M.D.

A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely. However, his implantable ...

Home March 17, 2021
Home
News | EP Lab

February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current ...

Home February 02, 2021
Home
News | Implantable Cardiac Monitor (ICM)

December 22, 2020 — The U.S. Food and Drug Administration (FDA) cleared Biotronik's Vital Data Sensor, which identifies ...

Home December 22, 2020
Home
Videos | EP Device Monitoring Systems

Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there has ...

Home December 22, 2020
Home
News | Implantable Cardiac Monitor (ICM)

July 7, 2020 – Medtronic announced it received U.S. Food and Drug Administration (FDA) clearance and European CE mark ...

Home July 07, 2020
Home
News | Implantable Cardiac Monitor (ICM)

June 29, 2020 — Boston Scientific received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx Inser ...

Home June 29, 2020
Home
Subscribe Now